Regulation of Osteoclast-mediated Bone Resorption by MicroRNA

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2022 May 10

PMID 35536437

Authors

Ling Ji

Xinyi Li

Shushu He

Song Chen

Affiliations

Soon will be listed here.

Abstract

Osteoclast-mediated bone resorption is responsible for bone metabolic diseases, negatively impacting people's health and life. It has been demonstrated that microRNA influences the differentiation of osteoclasts by regulating the signaling pathways during osteoclast-mediated bone resorption. So far, the involved mechanisms have not been fully elucidated. This review introduced the pathways involved in osteoclastogenesis and summarized the related microRNAs binding to their specific targets to mediate the downstream pathways in osteoclast-mediated bone resorption. We also discuss the clinical potential of targeting microRNAs to treat osteoclast-mediated bone resorption as well as the challenges of avoiding potential side effects and producing efficient delivery methods.

Citing Articles

The underlying mechanisms of the association of bone health with depression - an experimental study.

Houtenbos S, He Y, Cazzanelli P, Soultoukis G, Wuertz-Kozak K, Schulz T Mol Biol Rep. 2025; 52(1):163.

PMID: 39869252 PMC: 11772516. DOI: 10.1007/s11033-025-10230-x.

Molecular mechanism of bone metastasis in breast cancer.

Sui L, Wang J, Jiang W, Song X, Ye L Front Oncol. 2024; 14:1401113.

PMID: 39605887 PMC: 11599183. DOI: 10.3389/fonc.2024.1401113.

Anti-osteoporosis mechanism of resistance exercise in ovariectomized rats based on transcriptome analysis: a pilot study.

Wang Q, Weng H, Xu Y, Ye H, Liang Y, Wang L Front Endocrinol (Lausanne). 2023; 14:1162415.

PMID: 37664852 PMC: 10470051. DOI: 10.3389/fendo.2023.1162415.

Role of noncoding RNAs in orthodontic tooth movement: new insights into periodontium remodeling.

Chen Y, Zhang C J Transl Med. 2023; 21(1):101.

PMID: 36759852 PMC: 9912641. DOI: 10.1186/s12967-023-03951-9.

The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings.

Iwamoto N, Kawakami A Front Immunol. 2022; 13:998554.

PMID: 36172385 PMC: 9510592. DOI: 10.3389/fimmu.2022.998554.

References

Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D . miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015; 12(3):343-53. PMC: 4615895. DOI: 10.1080/15476286.2015.1017205. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

Ni J, Zhang X, Li J, Zheng Z, Zhang J, Zhao W . Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts. Cell Death Dis. 2021; 12(7):662. PMC: 8253828. DOI: 10.1038/s41419-021-03928-w. View

Li K, Chen S, Cai P, Chen K, Li L, Yang X . MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation. Mol Cell Probes. 2019; 49:101479. DOI: 10.1016/j.mcp.2019.101479. View

Zhang J, Zhao H, Chen J, Xia B, Jin Y, Wei W . Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett. 2012; 586(19):3255-62. DOI: 10.1016/j.febslet.2012.06.047. View

Wang Y, Grainger D . RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev. 2011; 64(12):1341-57. PMC: 3293106. DOI: 10.1016/j.addr.2011.09.002. View

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

Yang S, Zhang W, Cai M, Zhang Y, Jin F, Yan S . Suppression of Bone Resorption by miR-141 in Aged Rhesus Monkeys. J Bone Miner Res. 2018; 33(10):1799-1812. DOI: 10.1002/jbmr.3479. View

Boyce B, Rosenberg E, de Papp A, Duong L . The osteoclast, bone remodelling and treatment of metabolic bone disease. Eur J Clin Invest. 2012; 42(12):1332-41. DOI: 10.1111/j.1365-2362.2012.02717.x. View

10.

Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D . miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin. Med Sci Monit. 2018; 24:5292-5300. PMC: 6080580. DOI: 10.12659/MSM.908219. View

11.

Huang Z, Chu L, Liang J, Tan X, Wang Y, Wen J . H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p. Hepatology. 2021; 74(1):214-232. DOI: 10.1002/hep.31673. View

12.

Shalev M, Arman E, Stein M, Cohen-Sharir Y, Brumfeld V, Kapishnikov S . PTPRJ promotes osteoclast maturation and activity by inhibiting Cbl-mediated ubiquitination of NFATc1 in late osteoclastogenesis. FEBS J. 2021; 288(15):4702-4723. DOI: 10.1111/febs.15778. View

13.

Zhou Y, Zhu Y, Dong X, Cao G, Li Y, Fan Y . Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway. Onco Targets Ther. 2021; 14:2727-2739. PMC: 8064725. DOI: 10.2147/OTT.S282319. View

14.

Park J, Lee N, Lee S . Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation. Mol Cells. 2017; 40(10):706-713. PMC: 5682248. DOI: 10.14348/molcells.2017.0225. View

15.

Zhao H, Zhang J, Shao H, Liu J, Jin M, Chen J . miRNA-340 inhibits osteoclast differentiation via repression of MITF. Biosci Rep. 2017; 37(4). PMC: 5518531. DOI: 10.1042/BSR20170302. View

16.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

17.

Nakashima T, Takayanagi H . New regulation mechanisms of osteoclast differentiation. Ann N Y Acad Sci. 2012; 1240:E13-8. DOI: 10.1111/j.1749-6632.2011.06373.x. View

18.

Dinesh P, Kalaiselvan S, Sujitha S, Rasool M . miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway. J Cell Physiol. 2020; 235(12):9497-9509. DOI: 10.1002/jcp.29757. View

19.

Javed A, Chen H, Ghori F . Genetic and transcriptional control of bone formation. Oral Maxillofac Surg Clin North Am. 2010; 22(3):283-93, v. PMC: 2923651. DOI: 10.1016/j.coms.2010.05.001. View

20.

Xing L, Carlson L, Story B, Tai Z, Keng P, Siebenlist U . Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. J Bone Miner Res. 2003; 18(2):260-9. DOI: 10.1359/jbmr.2003.18.2.260. View